Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Biomolecules|July 29, 2023
Short Carbon Nanotube-Based Delivery of mRNA for HIV-1 VaccinesYang Xu, Tammy Ferguson, Kazuya Masuda, et al.Nature Communications|February 17, 2022
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccinesSvenja Weiss, Vincenza Itri, Ruimin Pan, et al.Plos One|December 14, 2011
Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structureMiroslaw K Gorny, Jared Sampson, Huiguang Li, et al.Virology|July 29, 2010
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffoldMaxim Totrov, Xunqing Jiang, Xiang-Peng Kong, et al.Frontiers in Immunology|September 5, 2022
Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine CandidateYang Xu, Ziyou Zhou, Brad Brooks, et al.Frontiers in Immunology|November 13, 2018
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex VaccinesCatarina E Hioe, Rajnish Kumar, Chitra Upadhyay, et al.Frontiers in Immunology|October 9, 2024
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicityChitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, et al.Journal of Virology|June 20, 2020
An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus MacaquesRebecca L Powell, Svenja Weiss, Alisa Fox, et al.Cell Reports|July 25, 2019
Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody ResponsesAnn J Hessell, Rebecca Powell, Xunqing Jiang, et al.Frontiers in Immunology|December 24, 2025
Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulationsClauvis Kunkeng Yengo, Xiaomei Liu, Gabriel Laghlali, et al.Pageof 3